Johnson & Johnson shares fall after company beats on earnings and revenue, but lowers pharmaceutical sales guidance

[ad_1] Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street’s expectations, but lowered its sales guidance for its pharmaceutical business. J&J, whose financial results are considered a bellwether for many health companies, said its sales during the quarter grew 5.6% over the same quarter last year.  related…

Read More